This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: F. Hoffmann-La Roche Ag, Genentech, Inc., Hoffmann-La Roche Inc.. Active years: 2025-2026.
Company Filing History:
1 out of 180 
1 out of 3,294 
1 out of 5,020 
Years Active: 2025-2026
Title: Michael Leiss: Innovator in Purification Platforms
Introduction
Michael Leiss is a notable inventor based in Schlehdorf, Germany. He has made significant contributions to the field of purification platforms, particularly in the pharmaceutical industry. His innovative work has led to the development of methods that enhance the efficiency of enzymatic hydrolysis processes.
Latest Patents
Michael Leiss holds 1 patent titled "Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform." This patent describes purification platforms that incorporate a depth filter step and/or a hydrophobic interaction chromatography (HIC) step. The methods outlined in this patent are designed to improve the use of these purification platforms and the pharmaceutical compositions derived from them.
Career Highlights
Throughout his career, Michael has worked with prominent companies in the biotechnology sector. He has been associated with Genentech, Inc. and Hoffmann-La Roche Inc., where he has contributed to various projects that focus on innovative solutions in drug development and purification processes.
Collaborations
Michael has collaborated with several professionals in his field, including Christian Meyer and Alexandra Thomas Morris. These collaborations have further enriched his work and have led to advancements in purification technologies.
Conclusion
Michael Leiss is a distinguished inventor whose work in purification platforms has made a significant impact on the pharmaceutical industry. His innovative methods and collaborations continue to influence advancements in this critical field.